S. Fourlanos

发表

P. Narendran, E. Estella, S. Fourlanos, 2005, QJM : monthly journal of the Association of Physicians.

Divided dosing reduces prednisolone-induced hyperglycaemia and glycaemic variability: a randomized trial after kidney transplantation.

S. Cohney, P. Colman, S. Fourlanos, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Latent autoimmune diabetes in adults (LADA) should be less latent

O. Rolandsson, L. Harrison, P. Colman, 2005, Diabetologia.

Type 1 diabetes: lessons for other autoimmune diseases?

G. Morahan, L. Harrison, M. Honeyman, 2008, Journal of autoimmunity.

A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults

L. Harrison, P. Colman, S. Fourlanos, 2006, Diabetes Care.

Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.

J. Krischer, H. Chase, G. Eisenbarth, 2007, The Journal of pediatrics.

Insulin resistance is a risk factor for progression to Type 1 diabetes

L. Harrison, P. Colman, P. Narendran, 2004, Diabetologia.

Autoantibody-Negative Type 1 Diabetes: A Neglected Subtype

J. Greenfield, S. Fourlanos, Cindy S. Ma, 2021, Trends in Endocrinology & Metabolism.

Recent advances in type 1 diabetes

P. Colman, S. Fourlanos, J. Wentworth, 2015, The Medical journal of Australia.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Metabolic outcomes in patients with diabetes mellitus administered SGLT2 inhibitors immediately before emergency or elective surgery: single centre experience and recommendations.

P. Colman, S. Fourlanos, M. Kyi, 2021, British journal of anaesthesia.

Beware ketoacidosis with SGLT2 inhibitors in latent autoimmune diabetes.

S. Fourlanos, Brendan J. Nolan, S. Varadarajan, 2020, The American journal of medicine.

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

T. Oron, M. Phillip, H. Rodbard, 2019, Diabetes Care.

A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes.

L. Harrison, P. Colman, S. Fourlanos, 2014, Diabetes research and clinical practice.

Factors that predict glycaemic response to sodium‐glucose linked transporter (SGLT) inhibitors

P. Colman, S. Fourlanos, J. Wentworth, 2020, Internal medicine journal.

Effects of closed-loop insulin delivery on glycemia during sleep and sleep quality in older adults with type 1 diabetes: results from the ORACL trial.

R. MacIsaac, V. Sundararajan, G. Ward, 2022, Diabetes technology & therapeutics.

Diabetes associated with immune checkpoint inhibition: presentation and management challenges

D. Rischin, P. Colman, S. Fourlanos, 2018, Diabetic medicine : a journal of the British Diabetic Association.

The Pro‐Diab Melbourne Perioperative Study: A structured pre‐admission perioperative diabetes management plan to improve medication usage in elective surgery

P. Colman, S. Fourlanos, M. Kyi, 2022, Diabetic medicine : a journal of the British Diabetic Association.

In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19

P. Colman, S. Fourlanos, L. Worth, 2022, BMJ Open Diabetes Research & Care.

The accelerator hypothesis and increasing incidence of type 1 diabetes

L. Harrison, P. Colman, S. Fourlanos, 2008, Current opinion in endocrinology, diabetes, and obesity.

Systemic mastocytosis identified in two women developing fragility fractures during lactation

R. MacIsaac, E. Seeman, S. Fourlanos, 2018, Osteoporosis International.

Immunity to self co-generates regulatory T cells

L. Harrison, L. Belov, S. Fourlanos, 2008 .

Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity

L. Harrison, S. Fourlanos, 2005, Pediatric diabetes.

Longitudinal prevalence of inpatient diabetes mellitus in an Australian hospital across five decades: 1972–2019

P. Colman, S. Fourlanos, M. Kyi, 2021, Internal medicine journal.

Type 1 diabetes: immunology, genetics and epidemiology

T. Kay, S. Fourlanos, 2003 .

Genetics of Diabetes in Childhood

G. Morahan, P. Wraight, L. Harrison, 2003 .

SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission.

D. O'Neal, R. MacIsaac, S. Fourlanos, 2019, The Journal of clinical endocrinology and metabolism.

Comment on ‘impact of routine Clinic Measurement of random Serum c‐peptide in people with a Clinician Diagnosis of type 1 diabetes’

J. Greenfield, S. Fourlanos, Shivani K Patel, 2021, Diabetic medicine : a journal of the British Diabetic Association.

Glucometric benchmarking in an Australian hospital enabled by networked glucose meter technology

P. Wraight, P. Colman, S. Fourlanos, 2019, The Medical journal of Australia.

Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes

L. Harrison, R. Mallone, P. Colman, 2011, Diabetes.

Glucose alert system improves health professional responses to adverse glycaemia and reduces the number of hyperglycaemic episodes in non‐critical care inpatients

P. Wraight, P. Colman, S. Fourlanos, 2018, Diabetic medicine : a journal of the British Diabetic Association.

The rising incidence of type 1 diabetes is accounted for by cases with lower risk HLA genotypes

G. Morahan, M. Varney, M. Honeyman, 2008 .

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

P. Gibbs, J. Desai, J. Tie, 2015, Journal of cancer epidemiology.

Glycaemia does not predict liver biochemistry in fatty liver disease

P. Colman, S. Fourlanos, K. Marion, 2012 .

Acute dysglycaemia in patients hospitalised with cancer

P. Colman, M. Rosenthal, S. Fourlanos, 2019 .

Oral vitamin D replacement is effective in chronic liver disease.

S. Fourlanos, A. Nicoll, A. Rode, 2010, Gastroenterologie clinique et biologique.

Feasibility study of a prototype extended‐wear insulin infusion set in adults with type 1 diabetes

D. Muchmore, S. Fourlanos, J. Joseph, 2022, Diabetes, obesity & metabolism.

Advanced Glycation End Products Are Direct Modulators of b -Cell Function

M. Knip, P. Groop, B. Kingwell, 2011 .

Prevalence of disordered eating in adults with type 1 diabetes in an Australian metropolitan hospital.

A. Ng, S. Fourlanos, A. Bramley, 2021, Health & social care in the community.

Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study.

Sybil A. McAuley, V. Sundararajan, G. Ward, 2022, The Lancet. Healthy longevity.

Diabetes IN hospital – Glucose and Outcomes in the COVID‐19 pandemic (DINGO COVID‐19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations

D. Kevat, R. MacIsaac, K. Buising, 2022, Internal medicine journal.

Reappraising the stereotypes of diabetes in the modern diabetogenic environment

L. Harrison, S. Fourlanos, J. Wentworth, 2009, Nature Reviews Endocrinology.

Advanced Glycation End Products Are Direct Modulators of β-Cell Function

M. Knip, J. Miyazaki, P. Groop, 2011, Diabetes.

The Rising Incidence of Type 1 Diabetes Is Accounted for by Cases With Lower-Risk Human Leukocyte Antigen Genotypes

G. Morahan, L. Harrison, M. Varney, 2008, Diabetes Care.

Body mass index correlates with ischemic heart disease and albuminuria in long-standing type 2 diabetes.

P. Colman, S. Fourlanos, J. Wentworth, 2012, Diabetes research and clinical practice.

Managing drug-induced hyponatraemia in adults

P. Greenberg, S. Fourlanos, 2003 .

Pooled genome wide association detects association upstream of FCRL3 with Graves’ disease

G. Montgomery, J. Craig, K. Burdon, 2016, BMC Genomics.

Natural History of Type 1 Diabetes

L. Harrison, P. Colman, S. Fourlanos, 2011 .

Latent Autoimmune Diabetes in Stiff-Person Syndrome

A. Evans, S. Fourlanos, A. Neal, 2014, Diabetes Care.

Lymphocytic hypophysitis in the elderly

S. Fourlanos, J. King, M. Gonzales, 2015, Journal of Clinical Neuroscience.

Severe hyponatraemia with cerebral oedema after Pfizer BNT162b2 mRNA vaccination against COVID-19

S. Fourlanos, S. Montalto, C. Chiang, 2023, IDCases.

Lipid lowering agents, cognitive decline, and dementia: the three-city study.

P. Barberger‐Gateau, C. Berr, K. Ritchie, 2012, Journal of Alzheimer's disease : JAD.

Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19

B. Christensen, S. Fourlanos, J. Lubel, 2020, Alimentary pharmacology & therapeutics.

Lived experience of older adults with type 1 diabetes using closed‐loop automated insulin delivery in a randomised trial

V. Sundararajan, G. Ward, S. Trawley, 2022, Diabetic medicine : a journal of the British Diabetic Association.

Carbohydrate-counting education for older adults with type 1 diabetes starting first-generation closed-loop therapy: Observations from the ORACL trial.

S. Fourlanos, S. A. McAuley, Kerryn Roem, 2022, Nutrition & dietetics: the journal of the Dietitians Association of Australia.

New‐Onset Diabetes After Kidney Transplantation—Changes and Challenges

J. Hjelmesæth, S. Cohney, P. Colman, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Factors associated with insulin‐induced weight gain in an Australian type 2 diabetes outpatient clinic

S. Fourlanos, J. Wentworth, P. Colman, 2016, Internal medicine journal.

Insulin resistance is a risk factor for progression to Type 1 diabetes

L. Harrison, P. Colman, P. Narendran, 2004, Diabetologia.

A pilot study of the feasibility of empagliflozin in recent-onset type 1 diabetes

L. Harrison, P. Colman, S. Fourlanos, 2020, Metabolism open.

Early Intervention for Diabetes in Medical and Surgical Inpatients Decreases Hyperglycemia and Hospital-Acquired Infections: A Cluster Randomized Trial

P. Wraight, A. Gorelik, P. Colman, 2019, Diabetes Care.

99mTc-Sestamibi Thyroid Scintigraphy in Amiodarone-Induced Thyrotoxicosis: Functional Imaging-Histopathologic Correlation.

M. Christie, N. Better, S. Fourlanos, 2022, Clinical nuclear medicine.

ANZSNM - 46th Annual Scientific Meeting, Rotorua, 22-25 April 2016 - 'Hot Science: An Eruption of Isotopes.'.

V. Bray, S. Fourlanos, D. Forstner, 2016, Internal medicine journal.

Blood pressure in adolescents and young adults with type 1 diabetes: data from the Australasian Diabetes Data Network registry

D. Pawlak, B. King, G. Ward, 2023, Acta Diabetologica.

Exercise habits and glucose management among older adults with type 1 diabetes using insulin pumps

P. Colman, S. Fourlanos, S. A. McAuley, 2022, Acta Diabetologica.

Contrast Increment and Decrement Processing in Individuals With and Without Diabetes

A. McKendrick, S. Fourlanos, R. Symons, 2023, Investigative ophthalmology & visual science.

Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial.

R. MacIsaac, V. Sundararajan, G. Ward, 2021, Diabetes care.

Glycemic outcome not predicted by baseline psychological measures in a diabetes management program.

S. Fourlanos, A. Hutchinson, A. Barker, 2012, Population health management.

Optimising diabetes in hospital: the integral role of an inpatient diabetes team

S. Fourlanos, R. Barmanray, M. Kyi, 2022, Internal medicine journal.

The Queensland Inpatient Diabetes Survey (QuIDS) 2019: the bedside audit of practice

S. Fourlanos, R. Barmanray, M. Kyi, 2022, Medical Journal of Australia.

Increased Hyperglycemia and Hospital-Acquired Infections Following Withdrawal of the RAPIDS Early Intervention Model of Diabetes Care in Medical and Surgical Inpatients

S. Fourlanos, M. Kyi, Joanna Wang, 2020, Diabetes Care.

Clinical Prediction Tool To Identify Adults With Type 2 Diabetes at Risk for Persistent Adverse Glycemia in Hospital.

P. Wraight, A. Gorelik, P. Colman, 2020, Canadian journal of diabetes.

Early intervention model of inpatient diabetes care improves glycemia following hospitalization.

P. Colman, S. Fourlanos, M. Kyi, 2023, Journal of hospital medicine.

Longitudinal Digital Glucometric Benchmarking to Evaluate the Impact of Institutional Diabetes Care Initiatives in Adults With Diabetes Mellitus Over the 2016-2020 Period.

P. Colman, S. Fourlanos, R. Barmanray, 2022, Journal of diabetes science and technology.

Nursing perceptions of the importance of blood glucose monitoring in hospital wards

S. Fourlanos, A. Dodds, K. Long, 2020 .

Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes.

A. Gorelik, P. Colman, S. Fourlanos, 2014, Obesity research & clinical practice.

Pooled genome wide association detects association upstream of FCRL3 with Graves’ disease

G. Montgomery, J. Craig, K. Burdon, 2016, BMC Genomics.

Higher body mass index in adults at diagnosis of the slowly progressive form of type 1 diabetes mellitus is associated with lower risk HLA genes.

L. Harrison, M. Varney, P. Colman, 2014, Diabetes Research and Clinical Practice.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Lipid lowering agents, cognitive decline, and dementia: the three-city study.

P. Barberger‐Gateau, C. Berr, K. Ritchie, 2012, Journal of Alzheimer's disease : JAD.

Coexisiting type 1 diabetes and celiac disease is associated with lower Hba1c when compared to type 1 diabetes alone: data from the Australasian Diabetes Data Network (ADDN) registry

M. Craig, K. Donaghue, S. Fourlanos, 2023, Acta Diabetologica.

The accelerator hypothesis and increasing incidence of type 1 diabetes

L. Harrison, P. Colman, S. Fourlanos, 2008, Current opinion in endocrinology, diabetes, and obesity.

Bone Density and Trabecular Bone Score Decline Rapidly in the First Year After Bone Marrow Transplantation with a Marked Increase in 10-Year Fracture Risk

S. Fourlanos, Y. Panek-Hudson, Joanna Y Gong, 2024, Calcified tissue international.

Classification of type 1 diabetes: A pathogenic and treatment-based classification.

S. Fourlanos, Shivani K. Patel, Jerry R. Greenfield, 2024, Diabetes & metabolic syndrome.

A Practical Limited Sampling Strategy to Predict Free Prednisolone Exposure and Glycemia in Kidney Transplant Recipients

S. Cohney, P. Colman, S. Fourlanos, 2013, Therapeutic drug monitoring.

End-of-Life Care Requires Caution with Use of Continuous Glucose Monitoring.

S. Fourlanos, B. Le, Rebecca Foskey, 2021, Journal of palliative medicine.